Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:INVA NYSE:NBR NASDAQ:WEN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINVAInnoviva$22.24+2.3%$22.90$16.52▼$25.15$1.60B0.38639,026 shs937,979 shsNBRNabors Industries$106.80-1.4%$88.58$23.27▼$112.90$1.60B1.01347,688 shs215,587 shsWENWendy's$7.75-4.6%$7.11$6.37▼$12.51$1.55B0.3512.97 million shs14.61 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINVAInnoviva-0.32%-4.44%-10.35%-8.16%+16.64%NBRNabors Industries-1.91%+6.35%+36.85%+44.13%+295.67%WENWendy's+3.57%+2.78%+16.83%-0.73%-34.20%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINVAInnoviva$22.24+2.3%$22.90$16.52▼$25.15$1.60B0.38639,026 shs937,979 shsNBRNabors Industries$106.80-1.4%$88.58$23.27▼$112.90$1.60B1.01347,688 shs215,587 shsWENWendy's$7.75-4.6%$7.11$6.37▼$12.51$1.55B0.3512.97 million shs14.61 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINVAInnoviva-0.32%-4.44%-10.35%-8.16%+16.64%NBRNabors Industries-1.91%+6.35%+36.85%+44.13%+295.67%WENWendy's+3.57%+2.78%+16.83%-0.73%-34.20%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINVAInnoviva 2.57Moderate Buy$36.2062.77% UpsideNBRNabors Industries 2.13Hold$93.63-12.33% DownsideWENWendy's 1.96Reduce$8.5610.41% UpsideCurrent Analyst Ratings BreakdownLatest WEN, INVA, and NBR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2026WENWendy's ArgusSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$12.005/12/2026WENWendy's TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$6.005/11/2026WENWendy's BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Perform$9.00 ➝ $8.005/11/2026WENWendy's CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$7.25 ➝ $7.755/11/2026WENWendy's JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral ➝ Underweight$7.00 ➝ $6.005/7/2026INVAInnoviva BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$35.00 ➝ $42.005/7/2026NBRNabors Industries BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeUnderweight ➝ Equal Weight$65.00 ➝ $99.005/4/2026NBRNabors Industries Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Hold (C-)5/1/2026WENWendy's MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$6.005/1/2026NBRNabors Industries CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$89.00 ➝ $110.004/30/2026WENWendy's Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$6.00(Data available from 5/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINVAInnoviva$411.33M3.99$5.15 per share4.32$18.18 per share1.22NBRNabors Industries$3.21B0.49$35.13 per share3.04$64.37 per share1.66WENWendy's$2.18B0.68$1.72 per share4.51$0.61 per share12.70Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINVAInnoviva$271.17M$6.013.708.90N/A119.89%33.33%22.67%8/5/2026 (Estimated)NBRNabors Industries$286.62M$12.778.3681.52N/A7.32%-8.66%-1.59%7/28/2026 (Estimated)WENWendy's$165.07M$0.789.9412.300.596.77%136.46%3.14%N/ALatest WEN, INVA, and NBR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2026Q1 2026WENWendy's$0.10$0.12+$0.02$0.12$518.03 million$432.30 million5/6/2026Q1 2026INVAInnoviva$0.43$0.44+$0.01$2.22$101.57 million$97.99 million4/28/2026Q1 2026NBRNabors Industries-$2.4907-$1.54+$0.9507-$1.54$769.33 million$783.55 million2/25/2026Q4 2025INVAInnoviva$0.34$1.94+$1.60$1.94$102.62 million$114.61 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthINVAInnovivaN/AN/AN/AN/AN/ANBRNabors IndustriesN/AN/A-100.00%N/AN/AWENWendy's$0.567.23%+18.23%71.79%N/ALatest WEN, INVA, and NBR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/8/2026WENWendy'squarterly$0.147.67%6/1/20266/1/20266/15/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINVAInnoviva0.1921.1320.07NBRNabors Industries2.221.971.82WENWendy's29.251.831.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINVAInnoviva99.12%NBRNabors Industries81.92%WENWendy's85.96%Insider OwnershipCompanyInsider OwnershipINVAInnoviva2.01%NBRNabors Industries5.41%WENWendy's17.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINVAInnoviva10073.81 million72.33 millionOptionableNBRNabors Industries13,90014.80 million14.00 millionOptionableWENWendy's14,900190.48 million157.91 millionOptionableWEN, INVA, and NBR HeadlinesRecent News About These CompaniesWendy's New CEO Has a Tough Job. Here's What Needs to Be Done.4 hours ago | barrons.comWendy's and 9 other major restaurants that are closing in MayMay 20 at 3:00 PM | msn.comBob Wright returns to Wendy’s as its CEOMay 20 at 3:00 PM | nrn.comNWendy’s appoints Bob Wright as CEOMay 20 at 3:00 PM | restaurantdive.comRWendy’s is hosting a Wendy lookalike competition in NYC next weekMay 20 at 3:00 PM | timeout.comTWendy's names Bob Wright as permanent CEOMay 20 at 3:00 PM | finance.yahoo.comWendy's brings back former COO Bob Wright as new chief executiveMay 20 at 3:00 PM | msn.comWendy's taps former Potbelly CEO to lead struggling burger chainMay 20 at 11:39 AM | cnbc.comWendy's Is Having a Wendy Lookalike Contest in New York City—Here's The Top PrizeMay 20 at 9:59 AM | yahoo.comWendy’s has the perfect Victor Wembanyama marketing ideaMay 20 at 9:59 AM | msn.comWendy’s Hires Bob Wright as CEOMay 20 at 9:59 AM | qsrmagazine.comQWendy's names restaurant industry veteran Wright as new CEOMay 20 at 9:59 AM | reuters.comWendy’s names Robert Wright as CEOMay 20 at 9:59 AM | msn.comWendy's Names Robert Wright as CEOMay 20 at 9:01 AM | wsj.comWendy's Appoints Robert D. "Bob" Wright as President and Chief Executive OfficerMay 20 at 8:30 AM | prnewswire.comWendy's look-alike contest, NYCMay 19 at 11:31 PM | msn.comWendy's embraces Wemby's special night with perfect decisionMay 19 at 11:31 PM | sports.yahoo.comThe '80s Rap Song Wendy's Wrote To Teach Employees 'Grill Skills' Will Stick In Your Head For DaysMay 19 at 11:31 PM | yahoo.comThe Forgotten Wendy's Burger Fans Agree Deserves A Revival: 'I Still Think About This Burger 15 Years Later'May 19 at 11:31 PM | yahoo.comWendy's Celebrates Its Redhead Roots with NYC Look-alike Contest on World Redhead DayMay 19 at 11:13 AM | prnewswire.comThe Wendy's Company (NASDAQ:WEN) Receives Average Rating of "Reduce" from BrokeragesMay 16, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026AMD’s Breakout Isn’t the Story—This Catalyst IsBy Thomas Hughes | April 24, 20262 Crypto Stocks Flashing Bullish Signals as Bitcoin Tops $75,000By Dan Schmidt | April 21, 2026Why Trump’s Amazon Stock Sale May Not Matter at AllBy Sam Quirke | May 19, 2026A Real Biggie Deal: Wendy's Serves Up a Juicy Buyout ArbitrageBy Jeffrey Neal Johnson | May 13, 2026WEN, INVA, and NBR Company DescriptionsInnoviva NASDAQ:INVA$22.24 +0.51 (+2.35%) Closing price 04:00 PM EasternExtended Trading$22.62 +0.38 (+1.69%) As of 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company's products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA) and umeclidinium bromide (UMEC) with a LABA, VI; GIAPREZA (angiotensin II), a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock; XERAVA (eravacycline) for the treatment of complicated intra-abdominal infections in adults; and XACDURO, a beta lactamase inhibitor for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Its development pipeline includes zoliflodacin, a late-stage product candidate, a potential single oral dose cure for the treatment of uncomplicated gonorrhea. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. It has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.Nabors Industries NYSE:NBR$106.80 -1.50 (-1.38%) Closing price 03:59 PM EasternExtended Trading$109.25 +2.46 (+2.30%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nabors Industries Ltd. provides drilling and drilling-related services for land-based and offshore oil and natural gas wells in the United States and internationally. The company operates through four segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. It provides tubular running services, including casing and tubing running, and torque monitoring; managed pressure drilling services; and drilling-bit steering systems and rig instrumentation software. The company also offers drilling systems comprising ROCKit, a directional steering control system; SmartNAV, a collaborative guidance and advisory platform; SmartSLIDE, a directional steering control system; and RigCLOUD, a digital infrastructure to integrate applications to deliver real-time insight into operations across the rig fleet. In addition, it operates a fleet of land-based drilling rigs and marketed platforms rigs; manufactures and sells top drives, catwalks, wrenches, drawworks, and other drilling related equipment, such as robotic systems and downhole tools; and provides aftermarket sales and services for the installed base of its equipment. Nabors Industries Ltd. was founded in 1952 and is based in Hamilton, Bermuda.Wendy's NASDAQ:WEN$7.75 -0.37 (-4.56%) Closing price 04:00 PM EasternExtended Trading$7.82 +0.07 (+0.84%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook AI Consolidation Begins: Blackstone & Google Forge an AI Empire The Great AI Rotation: Cashing In on Data Mirum Pharma: A Rare Disease Growth Story to Watch Vertical Aerospace: Pre-Flight Checks Point to a Breakout HIVE Weaponizes Power for an AI Pivot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
